What GLP-1 Medications Are Doing to Your Face, Body & Buttocks | Beauty and the Beasts Podcast

One in eight Americans is now on a GLP-1 medication. The weight loss results can be transformative, but what is happening to your face, your skin, your muscle, and your body in the process? In this episode, Dallas plastic surgeon Dr. Sam Jejurikar and San Diego plastic surgeon Dr. Sal Pacella break down the predictable patterns they are seeing in their practices every single day, and what can actually be done about it. They cover why GLP-1 medications cause volume loss in the face including the cheeks, lower eyelids, and temporal region, the difference between superficial and deep fat loss and why GLP-1s affect both, and why fat grafting results may not last as long in patients on these medications. Dr. Pacella calls Sculptra a "reverse ATM machine" while Dr. J makes the case for a more conservative, layered approach that he finds genuinely effective. They also debate the promise of AlloClae cadaveric fat grafting as a potential solution, dig into the underappreciated effects of GLP-1s on muscle mass and bone density, explain why brachioplasty and thigh lift cases have increased fivefold in recent years, and break down what is actually causing Ozempic butt and why the Brazilian Butt Lift is increasingly giving way to excisional lifting procedures for this patient population. Whether you are a patient on GLP-1 medications curious about your options, or a surgeon trying to stay ahead of what is reshaping the field, this conversation is for you. Subscribe for new episodes every two weeks. Follow Dr. Sam Jejurikar: @samjejurikar Follow Dr. Sal Pacella: @sandiegoplasticsurgeon #GLP1 #Ozempic #OzempicFace #OzempicBody #PlasticSurgery #BeautyAndTheBeasts #FatGrafting #Sculptra #BodyContouring #WeightLoss #Tirzepatide #CosmeticSurgery #DallasPlasticSurgery #SanDiegoPlasticSurgery